The Donders Centre for Cognition is a research institute for cognitive science, neuroscience and information technology. It was founded in 1986 as an integral part of the Faculty of Social Sciences at the Radboud University Nijmegen in The Netherlands.

During the past decade, Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour" #1 collaborator was "German Center for Neurodegenerative Diseases (DZNE)" with 2 trials as a collaborator and "German Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour" are "Late Onset Sporadic Cerebellar Ataxia" (1 trials), "Spastic Ataxia" (1 trials) and "Spinocerebellar Ataxia" (1 trials). Many other conditions were trialed in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour" in a lesser frequency.

Most popular intervention types in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour" are "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clinical rating scale to measure Ataxia disease severity and progression" (1 trials), "Clinical rating scale to measure spastic paraplegia disease severity and progression" (1 trials), "Disease-specific severity index for adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)" (1 trials) and "Next-Gen Sequencing (NGS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".